Has Fred Ingram, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,144 in general payments to Fred Ingram, MD across 455 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fred Ingram, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fred Ingram, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fred Ingram, MD

Obstetrics & Gynecology · Jackson, MSNPI 1508969213

Payments from drug & device makers

$8,144in general payments, 2019–2025

Across 455 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Astellas Pharma US Inc$848
Exeltis, USA Inc.$708
Takeda Pharmaceuticals U.S.A., Inc.$471
Amgen$369
Pfizer$344
plus $4K from 38 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	109	$1,865
Astellas Pharma US Inc	47	$848
Exeltis, USA Inc.	43	$708
Takeda Pharmaceuticals U.S.A., Inc.	26	$471
Amgen	15	$369
Pfizer	24	$344
Novo Nordisk	20	$313
Organon	18	$279
Lilly USA, LLC	13	$261
Mayne Pharma Commercial LLC	14	$239
Therapeuticsmd, Inc.	15	$214
Gynesonics, Inc.	1	$175
Daiichi Sankyo Inc.	8	$157
Hologic Sales And Service, LLC	9	$151
Radius Health, Inc.	9	$147
Biohaven Pharmaceuticals, Inc.	8	$139
Myriad Women's Health, Inc.	1	$132
Biohaven Pharmaceutical Holding Company Ltd.	6	$109
Shield Therapeutics Inc	5	$92
Medtronic	1	$92
Urovant Sciences Inc	3	$90
Roche Diagnostics Corporation	1	$87
Lupin Inc.	7	$87
Avion Pharmaceuticals	5	$78
Evofem Biosciences, Inc.	6	$77
Davol Inc.	3	$68
Bayer	5	$61
Sumitomo Pharma America, Inc.	4	$59
Nalpropion Pharmaceuticals LLC	4	$51
Eisai Inc.	3	$50
Merck	4	$47
BD	2	$34
Minerva Surgical, Inc	2	$32
Coopersurgical, Inc.	1	$30
Myovant Sciences Inc.	2	$25
Solventum Corporation	1	$25
AMAG Pharmaceuticals, Inc.	2	$24
Zyla Life Sciences, Inc.	2	$24
Currax Pharmaceuticals LLC	1	$18
Dexcom, Inc.	1	$18
Teva Pharmaceuticals USA, Inc.	1	$16
Gilead	1	$15
Boston Scientific	1	$14
Allegis Pharmaceuticals, LLC	1	$11

How this compares

$8,144 in reported general payments places this provider in the 90th percentile of 318 obstetrics & gynecology providers in Mississippi.

See all obstetrics & gynecology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$153,744

Medicare patients

393

Services billed

6,233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Jackson

Lori FultonJackson$102K
Sheila BouldinJackson$74K
Sarah NovotnyJackson$41K
Rachael MorrisJackson$28K
Jennifer MosesJackson$8K
Kathryn JeromeJackson$8K
John WooleyJackson$7K
Erica OryJackson$6K
Amanda NicolsJackson$6K
Leland GebhartJackson$5K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →